A Proof-of-concept Trial to Evaluate Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
Latest Information Update: 13 Feb 2024
At a glance
- Drugs Artesunate/mefloquine (Primary) ; Praziquantel
- Indications Schistosomiasis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Acronyms SchistoSAM
Most Recent Events
- 01 Jan 2024 Primary endpoint has been met. (Evaluate the efficacy of a single course of artesunate-mefloquine for the treatment of schistosomiasis, compared to the standard PZQ regimen: Parasitological cure rate), as per Results published in the Nature Medicine
- 01 Jan 2024 Results published in the Nature Medicine
- 02 Apr 2021 Status changed from active, no longer recruiting to completed.